Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Patrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, Takashi Muramatsu, Robert-Jan van Gems, Bernard de Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian Meredith, Cecile Dorange, Susan Veldhof, Karine Miguel Hebert, Richard Rapoza, John A Ormiston
EuroIntervention | EUROPA EDITION | Published : 2014
C. Dorange, S. Veldhof, K.M. Hebert and R. Rapoza are employees of Abbott Vascular. The other authors have no conflicts of interest to declare. The Guest Editor has received institutional research grants from several pharmaceutical and device companies, including Abbott Vascular and Biotronik and honoraria and fees on behalf of W. Wijns go to the Cardiovascular Research Center Aalst, Belgium.